Business
Cardiocomm Solutions Participates in Ontario Trade Mission to Japan and Korea
Toronto, Ontario--(Newsfile Corp. - February 22, 2018) - CardioComm Solutions, Inc. ("Cardio...
About this update from Cardiocomm Solutions, Inc.
[{"type":"text","content":"Cardiocomm Solutions Participates in Ontario Trade Mission to Japan and KoreaNew Software and Device Technology Innovations for Remote Patient Monitoring HighlightedToronto, Ontario--(Newsfile Corp. - February 22, 2018) - CardioComm Solutions, Inc. (\"CardioComm\" or the \"Company\") (TSXV: EKG) is participating in a series of meetings organized by the Ontario Trade Commission in partnership with Global Affairs Canada which has led to a delegation visit to Japan and Korea from February 20th to 27th. Through the assistance of the Trade Commission, meetings were held in November 2017 with visiting Japanese hospital representatives in Toronto in advance of CardioComm's visit to Japan. While in Japan and Korea, CardioComm has meetings set with additional hospital/medical groups and will have a booth presence in the Ontario Pavilion during the Medical Japan 2018 International Medical Expo & Conference. Medical Japan (www.medical-jpn.jp/en/) is one of the most important healthcare shows in Japan and was visited by over 29,000 visitors from the hospital, manufacturing, importation and distributors sectors in 2017.  The Company confirms that during the exposition discussions on distribution opportunities in Japan, Korea, Singapore and Thailand will be held. CardioComm is actively evaluating the Japanese, Korean and other regional markets for the clearance and sales of its newest HeartCheck™ ECG monitoring devices and introduction of its GEMS™ based SMART Monitoring ECG service. CardioComm's visit to Japan is at an opportune time as there have been directives issued from a panel under the Japanese Health, Labor and Welfare Ministry introducing new medical fee reimbursements related to the implementation of telemedicine platforms. Effective April 1, 2018, new fees for doctors offering counseling over the internet, as well as for telemedicine based services, will take effect including a fee for mobile ECG monitoring at a value of 1500 JPY (approximately Cdn$18) per ECG. The Japanese government has also revised the medical device regulatory review process to shorten and standardize the review time for medical device approval which will help foreign medical device companies to get their products on the Japanese market sooner. CardioComm itself has almost 20 years of Class II medical device clearances with Health Canada...